Braidwell
North America, Connecticut, United States, Stamford
Description
We serve the people and organizations that transform human health.
Investor Profile
Braidwell has made 23 investments, with 10 in the past 12 months and 17% as lead.
Stage Focus
- Post Ipo Equity (61%)
- Series A (13%)
- Series C (9%)
- Undisclosed (4%)
- Series B (4%)
- Debt Financing (4%)
- Post Ipo Debt (4%)
Country Focus
- United States (87%)
- France (4%)
- Sweden (4%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Therapeutics
- Life Science
- Medical Device
- Pharmaceutical
- Medical
- Oncology
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
